Utilization of statins in patients with type 2 diabetes mellitus: the practice in a lower middle income South Asian country

BACKGROUND: Cardiovascular disease (CVD) is a major cause of morbidity and mortality among patients with type 2 diabetes. Statin reduces CVD risk. The ACC/AHA 2018 guideline on dyslipidemia recommends all patients with type 2 diabetes mellitus to be given moderate-intensity statin. We aimed to deter...

Descripción completa

Detalles Bibliográficos
Autores principales: Matthias, Anne Thushara, Kaushalya, Jayamini, Somathilake, Gayasha, Garusinghe, Chaminda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263059/
https://www.ncbi.nlm.nih.gov/pubmed/35822081
http://dx.doi.org/10.1007/s13410-022-01107-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263059/
https://www.ncbi.nlm.nih.gov/pubmed/35822081
http://dx.doi.org/10.1007/s13410-022-01107-x

Ejemplares similares